Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1998
12/02/1998EP0880968A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
12/02/1998EP0880965A1 Topical pharmaceutical formulations containing nimesulide
12/02/1998EP0880963A2 Association of a retionoid with a polyamino-polymer
12/02/1998EP0880596A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells
12/02/1998EP0880530A1 Phosphatidyl oligoglycerols
12/02/1998EP0880352A2 Stabilization of naloxonhydrochlorid
12/02/1998EP0789561A4 Oral cyclosporin formulations
12/02/1998EP0783300B1 Starch products as tabletting excipient, method for preparing same, and method for making tablets
12/02/1998EP0717753B1 Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them
12/02/1998EP0681473B1 Compositions containing tandospirone or its analogs
12/02/1998EP0641200B1 2-arylpropionic acid compositions and process for preparing the same
12/02/1998EP0592594B1 Colestipol hydrochloride high-content tablets
12/02/1998CN1200677A Solid mixtures of cyclodextrins prepd. via melt-extrusion
12/02/1998CN1200676A Pharmaceutical compositions contg. platelet aggregation inhibitors
12/02/1998CN1200673A Eye drops
12/02/1998CN1200669A Oral gel capsule formulation of 1,2,4-benzotriazine oxides
12/02/1998CN1040946C Method for preparing orally administering agent to and through the peyer's patch
12/01/1998US5844107 Compacted nucleic acids and their delivery to cells
12/01/1998US5844089 Genetically fused globin-like polypeptides having hemoglobin-like activity
12/01/1998US5844088 Hemoglobin-like protein comprising genetically fused globin-like polypeptides
12/01/1998US5844039 Polymers comprising reversible hydrophobic functionalities
12/01/1998US5843930 Aqueous suspension with hydrolyzed polyvinyl alcohol viscosity modifier, non-ototoxic benzyl alcohol preservative, a polysorbate, and lecithin
12/01/1998US5843924 Intravenous alendronate formulations
12/01/1998US5843903 Targeted cytotoxic anthracycline analogs
12/01/1998US5843894 Methods for reduced renal uptake of antibody fragments
12/01/1998US5843893 Method for inhibiting the proliferation of epithelial lens cells and implantable lens therefor
12/01/1998US5843891 Pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
12/01/1998US5843887 Compositions for delivery of polypeptides, and methods
12/01/1998US5843883 Methods of wound healing and treating hyperproliferative diseases of epidermis comprising administering trunicated keratinocyte growh factor (KGF) having increased biological activity
12/01/1998US5843882 Antiviral proteins and peptides
12/01/1998US5843690 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
12/01/1998US5843653 Method for detecting a target molecule in a sample using a nucleic acid ligand
12/01/1998US5843643 Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid
12/01/1998US5843642 Methods for detection of acute promyelocytic leukemia (APL)
12/01/1998US5843641 Methods for the daignosis, of familial amyotrophic lateral sclerosis
12/01/1998US5843482 Products and processes for the treatment of the alimentary canal
12/01/1998US5843479 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
12/01/1998US5843473 Method of treatment of infected tissues
12/01/1998US5843468 Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
12/01/1998US5843466 Coolant compositions
12/01/1998US5843465 Emulsion formulation
12/01/1998US5843462 Diphtheria toxin epitopes
12/01/1998US5843461 Group B streptococcus type II polysaccharide-tetanus toxoid conjugate vaccines
12/01/1998US5843444 Conjugate vaccine for group B streptococcus
12/01/1998US5843440 Cellular and serum protein anchors for modulating pharmacokinetics
12/01/1998US5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/01/1998US5843397 Cytotoxic therapy for graft rejection
12/01/1998CA2125027C Stable microbubble suspensions as enhancement agents for ultrasound echography
12/01/1998CA2054213C Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same
12/01/1998CA2053346C Microcapsule compositions for torical treatment
12/01/1998CA2018573C Lyophilized preparation of 6-(3-dimethylaminopropionyl) forskolin
11/1998
11/26/1998WO1998052966A1 Tissue specific prodrug
11/26/1998WO1998052927A1 Composition for treating skin conditions
11/26/1998WO1998052614A2 Composition and method for enhancing transport across biological membranes
11/26/1998WO1998052613A2 Method of administration for a therapeutic agent utilizing suitable forms of hyaluronic acid and combinations with electroporation
11/26/1998WO1998052612A1 Antiseptic composition
11/26/1998WO1998052609A1 Sonodynamic therapy using an ultrasound sensitizer compound
11/26/1998WO1998052605A1 Immunopotentiating composition
11/26/1998WO1998052590A2 Improved delivery of disease modifiers
11/26/1998WO1998052579A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
11/26/1998WO1998052573A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity
11/26/1998WO1998052567A1 Method for treating headache pain with topical local anesthetic compositions
11/26/1998WO1998052561A1 Carotenoid formulation
11/26/1998WO1998052547A1 Gastroretentive controlled release microspheres for improved drug delivery
11/26/1998WO1998052543A1 Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
11/26/1998WO1998052542A1 Medicinal aerosol products
11/26/1998WO1998052415A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
11/26/1998WO1998036776A3 Gel delivery vehicles for anticellular proliferative agents
11/26/1998WO1998036733A3 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/26/1998CA2290546A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
11/26/1998CA2290461A1 Antiseptic composition
11/26/1998CA2290459A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
11/26/1998CA2285580A1 Gastroretentive controlled release microspheres for improved drug delivery
11/25/1998EP0879605A2 Glycosyl prodrug conjugate with enhanced tolerance
11/25/1998EP0879604A1 Konjugate comprising a Folic acid antagonist and a carrier
11/25/1998EP0879597A1 Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same
11/25/1998EP0879274A1 Technical di- and triglyceride mixtures
11/25/1998EP0879258A1 Copolymers with polyester polycarbonate blocks containing poly(caprolactone) segments, and use thereof for the preparation of biodegradable matrices
11/25/1998EP0879236A1 Derivatives of camptothecin for use in treating cancer
11/25/1998EP0879062A2 Nucleic acid delivery vehicle
11/25/1998EP0879050A1 Captopril tablets
11/25/1998EP0879048A1 Solid formulations containing trehalose
11/25/1998EP0815844B1 Topical surfactant-free oil-in-water emulsion containing a crosslinked neutralized polymer of 2-acrylamide-2-methylpropane sulfonic acid
11/25/1998EP0810868A4 Use of piperine as a bioavailability enhancer
11/25/1998EP0716595B1 Dispenser containing hydrophobic agent
11/25/1998EP0700283B1 Liquid antacid compositions
11/25/1998EP0697887B1 Stable liquid compositions of gamma interferon
11/25/1998EP0696920B1 Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
11/25/1998EP0689458B1 Active-substance patch for releasing estradiol to the skin
11/25/1998EP0639202B1 Stable polypeptide composition
11/25/1998EP0621773B1 Formulation and use of carotenoids in treatment of cancer
11/25/1998CN1200039A Bioconjugates of manganese complexes containing nitrogen macrocyclic ligand, and their application as catalysts of disproportionated super-oxide
11/25/1998CN1200038A Method for the production of tablets by pressing and tablets produced by the method
11/25/1998CN1200036A Compositions with anti-apoptotic activity, containing a mixture of phospholipids
11/25/1998CN1200032A Process to manufacture implants containing bioactive peptides
11/25/1998CN1199744A Block copolymers and their use as polymeric surfactants
11/25/1998CN1199643A Globular cellulose DNA immunoadsorbent
11/25/1998CN1199613A Preparation having increased in vivo tolerability
11/25/1998CN1040841C Producing method of base agent for preparation coating
11/24/1998US5840943 Esterifying a polyhydroxystearic acid having a degree of self-condensation of from 2 to 20 with polyglycerol component; emulsifiers
1 ... 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 ... 1712